Broker buying for 'big pharma' is obvious conclusion and why not buy in the $2-$3 range when they'll have to buyout in $25-$50 soon enough. The trading of 3-5mil over the past couple of days, when we've had a sell depth of 150-250k for the past couple of years tells you their aggressive approach has a time constraint in my opinion. It also tells you that the broker is buying and selling to themselves to create the illusion of shareholder vulnerability, which we all know doesn't exist. All in my opinion.
Broker buying for 'big pharma' is obvious conclusion...
-
- There are more pages in this discussion • 17,880 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.82 |
Change
-0.005(0.27%) |
Mkt cap ! $309.9M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.86 | $1.79 | $157.7K | 86.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5623 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |